Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/06/2006 | US20060147531 Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate |
07/06/2006 | US20060147530 Sustained release compositions containing alfuzosin |
07/06/2006 | US20060147529 Granulate comprising an oily substance, corresponding production method and tablet |
07/06/2006 | US20060147528 Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation |
07/06/2006 | US20060147527 Controlled release preparations comprising tramadol and topiramate |
07/06/2006 | US20060147526 Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines |
07/06/2006 | US20060147525 Lipophilic drug compositions |
07/06/2006 | US20060147524 Melt-formulated, multi-particulate oral dosage form |
07/06/2006 | US20060147523 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof |
07/06/2006 | US20060147522 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
07/06/2006 | US20060147521 Sustained release ranolazine formulations |
07/06/2006 | US20060147520 Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
07/06/2006 | US20060147519 Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
07/06/2006 | US20060147518 Water soluble; vinorelbine ditartrate in polyoxyethylene glycol; for oral administration |
07/06/2006 | US20060147517 Taste masking system for non-plasticizing drugs |
07/06/2006 | US20060147516 Taste masking system for alprazolam |
07/06/2006 | US20060147515 Bioactive dispersible formulation |
07/06/2006 | US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells |
07/06/2006 | US20060147513 Methods of forming targeted liposomes loaded with a therapeutic agent |
07/06/2006 | US20060147512 selectively exploit chemical variations between normal cells and cancer cells to inhibit or prevent the proliferation of cancerous cells; biologically acceptable copper compound |
07/06/2006 | US20060147511 Liposomal glucocorticoids |
07/06/2006 | US20060147510 Method for treating non-neuropathic pain |
07/06/2006 | US20060147509 Composition for vaccination |
07/06/2006 | US20060147507 Hot flash treatment system |
07/06/2006 | US20060147506 Foam with germproof and mildew-proof effects |
07/06/2006 | US20060147505 Water-dispersible wet wipe having mixed solvent wetting composition |
07/06/2006 | US20060147504 Feminine anti-itch cloth |
07/06/2006 | US20060147503 Oil absorbent wipe with high crumpability |
07/06/2006 | US20060147502 Methods for controlling microbial pathogens on currency and mail |
07/06/2006 | US20060147501 Collagen compositions and biomaterials |
07/06/2006 | US20060147498 Composition material for transmucosal delivery |
07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
07/06/2006 | US20060147493 Packaging and dispensing of rapid dissolve dosage form |
07/06/2006 | US20060147490 New polymers and applications |
07/06/2006 | US20060147488 increasing tear resistance of scar tissue during wound repair by applying to a wound a surgical mesh comprising an anabolic steroid and a corticosteroid disposed in or on a surgical mesh structure |
07/06/2006 | US20060147483 Hydrogel string medical device |
07/06/2006 | US20060147482 Oral liquid pharmaceutical composition of leukotriene antagonists |
07/06/2006 | US20060147481 Ketoprofen powder for oral use |
07/06/2006 | US20060147480 FDA Orange book listed patent for Follitropin alpha/beta a fertility drug; stable formulation, nonprecipitating, includes Pluronic F68 (aka Poloxamer 188), m-cresol as bacteriostat, diluent |
07/06/2006 | US20060147409 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eye for minimal invasive surgery; crosslinked synthetic polymer having electrophilic functional groups and dilysine, trilysine or tetralysine; dyes provide green color |
07/06/2006 | US20060147390 Cosmetic, dermatological or pharmaceutical preparations of lipid/wax mixtures containing gases |
07/06/2006 | US20060147389 Devices and pharmaceutical compositions for enhancing dosing efficiency |
07/06/2006 | US20060147388 Pharmaceutical compositions for nasal delivery |
07/06/2006 | US20060147387 Process to minimize loss through adhesion to equipment surfaces |
07/06/2006 | US20060147386 System and method for intranasal administration of lorazepam |
07/06/2006 | US20060147383 Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
07/06/2006 | US20060146557 Make-up applicator with led light source |
07/06/2006 | US20060145876 Medicine ingestion state management method, medicine and medicine ingestion state management device |
07/06/2006 | US20060145375 Method and apparatus for supercritical fluid assisted particle production |
07/06/2006 | US20060144973 Particle-size reduction apparatus, and use thereof |
07/06/2006 | US20060144535 Surface treatment with texturized microcrystalline cellulose microfibrils for improved paper and paper board |
07/06/2006 | DE202006006162U1 Diabetic socks, to prevent diabetic foot syndrome complications, comprises high silver concentration embedded in knitting, where the moisture is not absorbed by antiabsorbing layer and heat generated is quickly removed by air-opening cord |
07/06/2006 | DE102004061732A1 Controllable several storage cell system for e.g. material delivery, comprises a polymer storage cell, which has a hydrogel structure, a cell carrier, and a media |
07/06/2006 | DE102004035807B4 Device, useful to release/remove substances from inaccessible places, comprises goblet- and circular- shaped part intermediately arranged combined capsule, where one part is continuous magnetic and other is continuous- or soft magnetic |
07/06/2006 | CA2595162A1 Pulmonary surfactant formulations |
07/06/2006 | CA2593862A1 Nanoparticle composition and methods for synthesis thereof |
07/06/2006 | CA2593064A1 Hyaluronic acid linked with a polymer of an alpha hydroxy acid |
07/06/2006 | CA2592437A1 Lyophilization of virosomes |
07/06/2006 | CA2592423A1 Injectable non-aqueous suspension |
07/06/2006 | CA2592323A1 Stabilization of viral compositions |
07/06/2006 | CA2592035A1 Method of treating cancer |
07/06/2006 | CA2591761A1 Stable particulate pharmaceutical composition of solifenacin or salt thereof |
07/06/2006 | CA2591597A1 Novel galenic system for active principle transport, preparation method and use |
07/06/2006 | CA2591056A1 Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it |
07/06/2006 | CA2590239A1 Controlled release compositions |
07/06/2006 | CA2589632A1 Injectable non-aqueous suspension |
07/06/2006 | CA2589515A1 Method for producing sterile suspensions or lyophilisates of poorly soluble basic peptide complexes, pharmaceutical formulations containing the same, and use thereof as medicaments |
07/06/2006 | CA2587388A1 Visco-supplement composition and methods |
07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
07/05/2006 | EP1676895A1 Adhesive patch for external use on skin |
07/05/2006 | EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same |
07/05/2006 | EP1676602A1 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
07/05/2006 | EP1676588A1 Polyarginine-modified liposome capable of transferring into nucleus |
07/05/2006 | EP1676583A2 Therapeutic agent for periodontal disease |
07/05/2006 | EP1676582A1 Anti-coronavirus agent |
07/05/2006 | EP1676581A2 Polymer compositions for use in therapy |
07/05/2006 | EP1676580A1 Glycyrrhizin high-concentration preparation |
07/05/2006 | EP1676579A2 Use of sub-antimicrobial tetracyclines for treating ocular rosacea |
07/05/2006 | EP1676578A1 Method of stabilizing diarylvinylene compound |
07/05/2006 | EP1676569A1 Lyophilization of virosomes |
07/05/2006 | EP1676568A1 Particles comprising phospholipids, process of preparation and use as medicament |
07/05/2006 | EP1676561A2 Compositions containing a biocatalytic polyphasic system and the use thereof |
07/05/2006 | EP1675942A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
07/05/2006 | EP1675891A1 Pectin films prepared from gamma irradiated pectin |
07/05/2006 | EP1675869A2 Stabilised compositions |
07/05/2006 | EP1675652A2 Treatment of ocular disease |
07/05/2006 | EP1675635A1 Administration of medicinal dry powders |
07/05/2006 | EP1675619A1 Sustained release l-arginine formulations and methods of manufacture and use |
07/05/2006 | EP1675614A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
07/05/2006 | EP1675612A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
07/05/2006 | EP1675604A1 Capsulated herbal composition as auxilary medicament against diabetes mellitus type (i) and (ii) |
07/05/2006 | EP1675602A1 Remedy ointment for piles and their manufacturing method |
07/05/2006 | EP1675599A1 Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof |
07/05/2006 | EP1675596A2 Method |
07/05/2006 | EP1675591A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor |
07/05/2006 | EP1675583A1 Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof |
07/05/2006 | EP1675581A1 TREATMENT OF GASTROPARESIS AND NONULCER DYSPEPSIA WITH GABA-b AGONISTS |
07/05/2006 | EP1675580A1 Natural menaquinone 7 compositions |
07/05/2006 | EP1675577A2 Patch |
07/05/2006 | EP1675576A1 A method for preparing modified release pharmaceutical compositions |